Weekly Digest: a new vulnerability is published on the National Vulnerability Database (49 items)

New vulnerabilities from the NVD: CVE-2019-25019 LimeSurvey before 4.0.0-RC4 allows SQL injection via the participant model. Published at: February 14, 2021 at 06:15AM View on website February 14, 2021 at 08:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-24899 Nagios XI 5.7.2 is affected by a remote code execution (RCE) vulnerability. An authenticated user can inject additional commands into normal webapp query. Published at: February 15, 2021 at 08:15PM View on website February 15, 2021 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-22427 NagiosXI 5.6.11 is affected by a remote code execution (RCE) vulnerability. An authenticated user can inject additional commands into a request. Published at: February 15, 2021 at 08:15PM View on website February 15, 2021 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-22425 Centreon 19.10-3.el7 is affected by a SQL injection vulnerability, where an authorized user is able to inject additional SQL queries to perform remote command execution. Published at: February 15, 2021 at 08:15PM View on website February 15, 2021 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-1974 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2020. Notes: none. Published at: February 16, 2021 at 12:15AM View on website February 16, 2021 at 01:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-1973 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2020. Notes: none. Published at: February 16, 2021 at 12:15AM View on website February 16, 2021 at 01:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-1972 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2020. Notes: none. Published at: February 16, 2021 at 12:15AM View on website February 16, 2021 at 01:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-1970 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2020. Notes: none. Published at: February 16, 2021 at 12:15AM View on website February 16, 2021 at 01:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-1969 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2020. Notes: none. Published at: February 16, 2021 at 12:15AM View on website February 16, 2021 at 01:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-1966 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2020. Notes: none. Published at: February 16, 2021 at 12:15AM View on website February 16, 2021 at 01:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-24841 PNPSCADA 2.200816204020 allows SQL injection via parameter 'interf' in /browse.jsp. Exploiting this issue could allow an attacker to compromise the application, access or modify data, or exploit latent vulnerabilities in the underlying database. Published at: February 16, 2021 at 03:15PM View on website February 16, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-25340 An issue was discovered in NFStream 5.2.0. Because some allocated modules are not correctly freed, if the nfstream object is directly destroyed without being used after it is created, it will cause a memory leak that may result in a local denial of service (DoS). Published at: February 16, 2021 at 05:15PM View on website February 16, 2021 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-11635 The Zscaler Client Connector prior to 3.1.0 did not sufficiently validate RPC clients, which allows a local adversary to execute code with system privileges or perform limited actions for which they did not have privileges. Published at: February 16, 2021 at 10:15PM View on website February 16, 2021 at 11:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-2502 This cross-site scripting vulnerability in Photo Station allows remote attackers to inject malicious code. QANP We have already fixed this vulnerability in the following versions of Photo Station. Photo Station 6.0.11 and later Published at: February 17, 2021 at 06:15AM View on website February 17, 2021 at 08:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-2501 A stack-based buffer overflow vulnerability has been reported to affect QNAP NAS devices running Surveillance Station. If exploited, this vulnerability allows attackers to execute arbitrary code. QNAP have already fixed this vulnerability in the following versions: Surveillance Station 5.1.5.4.3 (and later) for ARM CPU NAS (64bit OS) and x86 CPU NAS (64bit OS) Surveillance Station 5.1.5.3.3 (and later) for ARM CPU NAS (32bit OS) and x86 CPU NAS (32bit OS) Published at: February 17, 2021 at 06:15AM View on website February 17, 2021 at 08:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12386 Out-of-bounds write in some Intel(R) Graphics Drivers before version 15.36.39.5143 may allow an authenticated user to potentially enable denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12385 Improper input validation in some Intel(R) Graphics Drivers before version 26.20.100.8141 may allow a privileged user to potentially enable escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12384 Improper access control in some Intel(R) Graphics Drivers before version 26.20.100.8476 may allow an authenticated user to potentially enable an escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12380 Out of bounds read in the BMC firmware for some Intel(R) Server Boards, Server Systems and Compute Modules before version 2.47 may allow an authenticated user to potentially enable escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12377 Insufficient input validation in the BMC firmware for some Intel(R) Server Boards, Server Systems and Compute Modules before version 2.47 may allow an authenticated user to potentially enable escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12376 Use of hard-coded key in the BMC firmware for some Intel(R) Server Boards, Server Systems and Compute Modules before version 2.47 may allow authenticated user to potentially enable information disclosure via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12375 Heap overflow in the BMC firmware for some Intel(R) Server Boards, Server Systems and Compute Modules before version 2.47 may allow an authenticated user to potentially enable escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12373 Buffer overflow in the BMC firmware for some Intel(R) Server Boards, Server Systems and Compute Modules before version 2.47 may allow a privileged user to potentially enable escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12372 Unchecked return value in some Intel(R) Graphics Drivers before version 26.20.100.8141 may allow a privileged user to potentially enable a denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12371 Divide by zero in some Intel(R) Graphics Drivers before version 26.20.100.8141 may allow a privileged user to potentially enable a denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12370 Untrusted pointer dereference in some Intel(R) Graphics Drivers before version 26.20.100.8141 may allow a privileged user to potentially enable a denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12369 Out of bound write in some Intel(R) Graphics Drivers before version 26.20.100.8336 may allow a privileged user to potentially enable escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12368 Integer overflow in some Intel(R) Graphics Drivers before version 26.20.100.8141 may allow a privileged user to potentially enable an escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12367 Integer overflow in some Intel(R) Graphics Drivers before version 26.20.100.8476 may allow a privileged user to potentially enable an escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12366 Insufficient input validation in some Intel(R) Graphics Drivers before version 27.20.100.8587 may allow a privileged user to potentially enable an escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12364 Null pointer reference in some Intel(R) Graphics Drivers for Windows* before version 26.20.100.7212 and before version Linux kernel version 5.5 may allow a privileged user to potentially enable a denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12363 Improper input validation in some Intel(R) Graphics Drivers for Windows* before version 26.20.100.7212 and before Linux kernel version 5.5 may allow a privileged user to potentially enable a denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12362 Integer overflow in the firmware for some Intel(R) Graphics Drivers for Windows * before version 26.20.100.7212 and before Linux kernel version 5.5 may allow a privileged user to potentially enable an escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12361 Use after free in some Intel(R) Graphics Drivers before version 15.33.51.5146 may allow an authenticated user to potentially enable denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12339 Insufficient control flow management in the API for the Intel(R) Collaboration Suite for WebRTC before version 4.3.1 may allow an authenticated user to potentially enable escalation of privilege via network access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-0544 Insufficient control flow management in the kernel mode driver for some Intel(R) Graphics Drivers before version 15.36.39.5145 may allow an authenticated user to potentially enable escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-0525 Improper access control in firmware for the Intel(R) Ethernet I210 Controller series of network adapters before version 3.30 may allow a privileged user to potentially enable denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-0524 Improper default permissions in the firmware for the Intel(R) Ethernet I210 Controller series of network adapters before version 3.30 may allow an authenticated user to potentially enable denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-0523 Improper access control in the firmware for the Intel(R) Ethernet I210 Controller series of network adapters before version 3.30 may potentially allow a privileged user to enable a denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-0522 Improper initialization in the firmware for the Intel(R) Ethernet I210 Controller series of network adapters before version 3.30 may allow a privileged user to potentially enable denial of service via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-0521 Insufficient control flow management in some Intel(R) Graphics Drivers before version 15.45.32.5145 may allow an authenticated user to potentially enable escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-0518 Improper access control in the Intel(R) HD Graphics Control Panel before version 15.40.46.5144 and 15.36.39.5143 may allow an authenticated user to potentially enable escalation of privilege via local access. Published at: February 17, 2021 at 04:15PM View on website February 17, 2021 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12365 Untrusted pointer dereference in some Intel(R) Graphics Drivers before versions 15.33.51.5146, 15.45.32.5145, 15.36.39.5144 and 15.40.46.5143 may allow an authenticated user to potentially denial of service via local access. Published at: February 17, 2021 at 05:15PM View on website February 17, 2021 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2019-18255 HMI/SCADA iFIX (Versions 6.1 and prior) allows a local authenticated user to modify system-wide iFIX configurations through section objects. This may allow privilege escalation. Published at: February 18, 2021 at 05:15PM View on website February 18, 2021 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2019-18243 HMI/SCADA iFIX (Versions 6.1 and prior) allows a local authenticated user to modify system-wide iFIX configurations through the registry. This may allow privilege escalation. Published at: February 18, 2021 at 07:15PM View on website February 18, 2021 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2019-25024 OpenRepeater (ORP) before 2.2 allows unauthenticated command injection via shell metacharacters in the functions/ajax_system.php post_service parameter. Published at: February 19, 2021 at 06:15AM View on website February 19, 2021 at 08:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-10254 An issue was discovered in ownCloud before 10.4. An attacker can bypass authentication on a password-protected image by displaying its preview. Published at: February 19, 2021 at 09:15AM View on website February 19, 2021 at 01:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-10252 An issue was discovered in ownCloud before 10.4. Because of an SSRF issue (via the apps/files_sharing/external remote parameter), an authenticated attacker can interact with local services blindly (aka Blind SSRF) or conduct a Denial Of Service attack. Published at: February 19, 2021 at 09:15AM View on website February 19, 2021 at 01:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12374 Buffer overflow in the BMC firmware for some Intel(R) Server Boards, Server Systems and Compute Modules before version 2.47 may allow a privileged user to potentially enable escalation of privilege via local access. Published at: February 19, 2021 at 06:15PM View on website February 19, 2021 at 07:36PM via National Vulnerability Database

Weekly Digest: New diabetes clinical trial (23 items)

New diabetes clinical trial: A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus Published on: February 15, 2021 at 07:00PM Condition:   T2DM (Type 2 Diabetes Mellitus) Interventions:   Drug: ORMD-0801;   Other: Placebo Sponsors:   Oramed, Ltd.;   Integrium Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04754334?term=diabetes&sfpd_d=14 February 15, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Randomised, Controlled, Double-blind Clinical Study on the Effect of a Synbiotic on Body Fat Mass Published on: February 15, 2021 at 07:00PM Conditions:   Type 2 Diabetes;   Metabolic Syndrome;   Obesity, Abdominal;   Obesity, Visceral Interventions:   Dietary Supplement: verum;   Dietary Supplement: control Sponsors:   Slimbiotics GmbH;   Clinical Research Center Kiel GmbH Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT04754464?term=diabetes&sfpd_d=14 February 15, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Telehealth Family Coaching With Type 1 Diabetes Published on: February 15, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 1 Intervention:   Behavioral: occupation-based coaching Sponsors:   Creighton University;   DexCom, Inc. Recruiting https://clinicaltrials.gov/ct2/show/NCT04753099?term=diabetes&sfpd_d=14 February 15, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes Published on: February 15, 2021 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Other: Maximal ATP Production (ATPmax);   Other: Exercise Testing (VO2max);   Procedure: Muscle Biopsy;   Procedure: Adipose Tissue Biopsy;   Other: Hyperinsulinemic euglycemic clamp;   Other: PET imaging Sponsor:   Translational Research Institute for Metabolism and Diabetes, Florida Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04754581?term=diabetes&sfpd_d=14 February 15, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: The Diabetes Transition Study for Young People Aged Between 16-20 Years of Age. Published on: February 15, 2021 at 07:00PM Condition:   Type 1 Diabetes Mellitus Interventions:   Other: Transition intervention group;   Other: Post transition group Sponsor:   Northampton General Hospital NHS Trust Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT04754919?term=diabetes&sfpd_d=14 February 15, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Glucose Levels in Early Pregnancy and Feto-maternal Outcome Published on: February 16, 2021 at 07:00PM Condition:   Maternal Diabetes Intervention:   Other: Observation of their fetomaternal outcome Sponsor:   University of Jordan Completed https://clinicaltrials.gov/ct2/show/NCT04756102?term=diabetes&sfpd_d=14 February 16, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Home-based Resistance Training to Patients With Type 2 Diabetes Published on: February 16, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Behavioral: Exercise behavior change for resistance exercise Sponsors:   National Taipei University of Nursing and Health Sciences;   Taiwan Nurses Association Recruiting https://clinicaltrials.gov/ct2/show/NCT04755660?term=diabetes&sfpd_d=14 February 16, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps) Published on: February 16, 2021 at 07:00PM Conditions:   T1DM;   Health Related Quality of Life;   Insulin Pump Intervention:   Other: Health related quality of life Sponsor:   Ain Shams University Completed https://clinicaltrials.gov/ct2/show/NCT04756011?term=diabetes&sfpd_d=14 February 16, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention. Published on: February 17, 2021 at 07:00PM Condition:   Diabetes Interventions:   Behavioral: DPP-GLB Standard;   Behavioral: DPP-GLB Enhanced Sponsors:   Lovoria Williams;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04757519?term=diabetes&sfpd_d=14 February 17, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Carbohydrates Under Target for Type 1 Diabetes Management Published on: February 17, 2021 at 07:00PM Condition:   Type 1 Diabetes Interventions:   Other: Insulin treatment optimization with participant's usual diet;   Device: Abbott's FreeStyle Libre;   Other: Three-day food journal;   Other: Medical visit;   Other: Blood pressure measurements;   Other: Anthropometric parameters measurements;   Other: Indirect calorimetry test;   Other: Well-being questionnaire;   Other: Diet appreciation questionnaire;   Device: Pedometer (PiezoRxD);   Other: Hepatic imaging (MRI);   Other: Glucagon efficiency test;   Other: Body composition : Dual Energy X-ray absorptiometry (DEXA);   Other: Blood tests;   Other: Stool sample collections (optional);   Other: Hypoglycemia journal;   Other: Ketone journal;   Other: Adherence to the diet (Keenoa) Sponsors:   Institut de Recherches Cliniques de Montreal;   McGill University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04758858?term=diabetes&sfpd_d=14 February 17, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Telemedicine in Patients With Type 1 Diabetes Mellitus. Published on: February 17, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 1 Intervention:   Other: Telemedicine Sponsor:   Consorci Sanitari de l'Alt Penedès i Garraf Recruiting https://clinicaltrials.gov/ct2/show/NCT04758884?term=diabetes&sfpd_d=14 February 17, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Personalizing Self-management in Diabetes - Pilot Study Published on: February 17, 2021 at 07:00PM Condition:   Type 2 Diabetes Mellitus Intervention:   Behavioral: GlucoType Sponsors:   Columbia University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Completed https://clinicaltrials.gov/ct2/show/NCT04757233?term=diabetes&sfpd_d=14 February 17, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: FASter Insulin in Closed-loop Technology in Children Published on: February 18, 2021 at 07:00PM Condition:   Type 1 Diabetes Mellitus Interventions:   Device: CamAPS FX using faster insulin aspart;   Device: CamAPS FX using standard insulin aspart Sponsors:   University of Cambridge;   Cambridge University Hospitals NHS Foundation Trust;   Oxford University Hospitals NHS Trust;   Nottingham University Hospitals NHS Trust Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04759144?term=diabetes&sfpd_d=14 February 19, 2021 at 12:24AM via ClinicalTrials.gov New diabetes clinical trial: Is Real-time CGM Superior to Flash Glucose Monitoring in Real Life Study (CORRIDA LIFE) Published on: February 18, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 1 Interventions:   Device: Continuous Glucose Monitoring Dexcom G5 and G6 system (real-time continuous glucose monitoring);   Device: Continuous Glucose Monitoring FreeStyle Libre Flash system (flash glucose monitoring) Sponsor:   Charles University, Czech Republic Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT04759495?term=diabetes&sfpd_d=14 February 19, 2021 at 12:24AM via ClinicalTrials.gov New diabetes clinical trial: A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before Published on: February 18, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Insulin icodec;   Drug: Insulin Glargine 100U/mL;   Drug: Insulin Degludec;   Drug: Insulin Glargine 300U/mL Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04760626?term=diabetes&sfpd_d=14 February 19, 2021 at 12:24AM via ClinicalTrials.gov New diabetes clinical trial: Clinical Efficacy of Insulin Pumps in Type 1 Diabetes Mellitus Patients in Spain Published on: February 18, 2021 at 07:00PM Condition:   Type 1 Diabetes Intervention:   Device: Insulin pump Sponsors:   Castilla-La Mancha Health Service;   Spanish Diabetes Association Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04761094?term=diabetes&sfpd_d=14 February 19, 2021 at 12:24AM via ClinicalTrials.gov New diabetes clinical trial: Michigan Men's Diabetes Project Published on: February 18, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Behavioral: Peer Leader Diabetes Self-Management Support;   Behavioral: Virtual Diabetes Self-Management Education Sponsors:   University of Michigan;   Blue Cross Blue Shield of Michigan Foundation;   National Institutes of Health (NIH);   National Institute on Aging (NIA) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04760444?term=diabetes&sfpd_d=14 February 19, 2021 at 12:24AM via ClinicalTrials.gov New diabetes clinical trial: Efficacy of Pythagorean Self-Awareness for Aging Biomarkers Improvement, in T2D Patients and Healthy Individuals. Published on: February 19, 2021 at 07:00PM Conditions:   Type 2 Diabetes Mellitus;   Telomere Shortening Intervention:   Behavioral: Pythagorean Self-Awareness Intervention(PSAI) Sponsors:   National and Kapodistrian University of Athens;   National Hellenic Research Foundation, Athens, Greece;   Laikο General Hospital, Athens;   Aghia Sophia Children's Hospital of Athens;   University of Thessaly Completed https://clinicaltrials.gov/ct2/show/NCT04763525?term=diabetes&sfpd_d=14 February 21, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Virtual Diabetes Specialty Clinic: A Study Evaluating Remote Initiation of Continuous Glucose Monitoring Published on: February 22, 2021 at 07:00PM Conditions:   Type 1 Diabetes;   Type 2 Diabetes Intervention:   Other: Virtual Clinic Sponsor:   Jaeb Center for Health Research Recruiting https://clinicaltrials.gov/ct2/show/NCT04765358?term=diabetes&sfpd_d=14 February 21, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: A Rural OPTIFAST Intervention for Partial Remission of Type 2 Diabetes in Adults With Obesity Published on: February 22, 2021 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Obesity Intervention:   Dietary Supplement: OPTIFAST dietary supplement Sponsor:   Marathon Family Health Team Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04764279?term=diabetes&sfpd_d=14 February 21, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Polyphenol Enriched Extra-virgin Olive Oil and Postprandial Glycemia in Type 1 Diabetes (DOP) Published on: February 22, 2021 at 07:00PM Condition:   Type 1 Diabetes Interventions:   Other: EVOO+POLY;   Other: OO-POLY Sponsor:   Federico II University Completed https://clinicaltrials.gov/ct2/show/NCT04764786?term=diabetes&sfpd_d=14 February 21, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes Published on: February 22, 2021 at 07:00PM Conditions:   Type 1 Diabetes;   Hypoglycemia Intervention:   Drug: Dasiglucagon Sponsor:   Steno Diabetes Center Copenhagen Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04764968?term=diabetes&sfpd_d=14 February 21, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Type 2 Diabetes and Bone Microarchitecture Published on: February 22, 2021 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Other: Patients with Type 2 diabetes;   Other: Placebo Sponsor:   Hospices Civils de Lyon Completed https://clinicaltrials.gov/ct2/show/NCT04765631?term=diabetes&sfpd_d=14 February 21, 2021 at 02:24PM via ClinicalTrials.gov

Weekly Digest: New diabetes clinical trial (18 items)

New diabetes clinical trial: Automated Screening of Diabetic Retinopathy Using a Smartphone-based Camera Published on: February 01, 2021 at 07:00PM Condition:   Diabetic Retinopathy Intervention:   Diagnostic Test: Colour fundus photography Sponsor:   Tameside General Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04732208?term=diabetes&sfpd_d=14 February 01, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Effects of Pilates Exercises Versus Walking on Mechanical and Vascular Variables of Individuals With Type 2 Diabetes Mellitus Published on: February 01, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Other: Pilates exercises;   Other: Walking protocol Sponsor:   Federal University of Rio Grande do Sul Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04732611?term=diabetes&sfpd_d=14 February 01, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Avoidance of Hyperglycaemia in People With Type 1 Diabetes Published on: February 01, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 1 Intervention:   Other: No intervention Sponsors:   Imperial College London;   Imperial College Healthcare NHS Trust;   Imperial Health Charity Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04732780?term=diabetes&sfpd_d=14 February 01, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections. Published on: February 02, 2021 at 07:00PM Conditions:   Type 2 Diabetes;   Urinary Tract Infections Interventions:   Drug: Empagliflozin / Linagliptin or Dapagliflozin/Saxagliptin Pill;   Drug: Empagliflozin or Dapagliflozin Pill Sponsor:   University of Pisa Recruiting https://clinicaltrials.gov/ct2/show/NCT04735042?term=diabetes&sfpd_d=14 February 02, 2021 at 05:24PM via ClinicalTrials.gov New diabetes clinical trial: METABOLIC CHARACTERISTICS OF A NOVEL COMMON BEAN PRODUCT Published on: February 02, 2021 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Dietary Supplement: Common bean product Sponsors:   Jomo Kenyatta University of Agriculture and Technology;   KU Leuven;   Legumes Centre of Excellence for Food and Nutrition Security;   VLIR-UOS Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04733690?term=diabetes&sfpd_d=14 February 02, 2021 at 05:24PM via ClinicalTrials.gov New diabetes clinical trial: The Effects of Short Message Notifications on Middle-Aged Diabetic Patients Published on: February 02, 2021 at 07:00PM Condition:   Type2 Diabetes Mellitus Intervention:   Other: Informative messages Sponsor:   Istanbul University Completed https://clinicaltrials.gov/ct2/show/NCT04733612?term=diabetes&sfpd_d=14 February 02, 2021 at 05:24PM via ClinicalTrials.gov New diabetes clinical trial: Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes Published on: February 02, 2021 at 07:00PM Conditions:   Diabetes Mellitus;   Diabetes Mellitus, Type 2 Interventions:   Drug: 111In-DTPA-exendin-4;   Drug: IRDye800CW-exendin-4 Sponsors:   Radboud University;   University of Coimbra Recruiting https://clinicaltrials.gov/ct2/show/NCT04733508?term=diabetes&sfpd_d=14 February 02, 2021 at 05:24PM via ClinicalTrials.gov New diabetes clinical trial: Together Overcoming Diabetes Published on: February 02, 2021 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Behavioral: Together Overcoming Diabetes (TOD) Sponsors:   Johns Hopkins Bloomberg School of Public Health;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04734015?term=diabetes&sfpd_d=14 February 02, 2021 at 05:24PM via ClinicalTrials.gov New diabetes clinical trial: Effects of the Insulin Self Titration Education for Type 2 Diabetes Mellitus Patients Published on: February 03, 2021 at 07:00PM Condition:   Type2 Diabetes Intervention:   Other: Insulin Self-Titration Education Program Sponsors:   National Taipei University of Nursing and Health Sciences;   Chiayi Christian Hospital Completed https://clinicaltrials.gov/ct2/show/NCT04736225?term=diabetes&sfpd_d=14 February 03, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF Published on: February 04, 2021 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Heart Failure With Preserved Ejection Fraction Interventions:   Drug: Dapagliflozin 10 MG [Farxiga];   Drug: Placebo Sponsors:   Hospital General Universitario Gregorio Marañon;   University of Navarra;   Instituto de Salud Carlos III;   Fundación para la Investigación Biomédica del Hospital Gregorio Maranon Recruiting https://clinicaltrials.gov/ct2/show/NCT04739215?term=diabetes&sfpd_d=14 February 04, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Appropriation of the Connected Solution Freestyle Libre® in Adult Patients With Diabetes in the Context of Therapeutic Education Published on: February 04, 2021 at 07:00PM Condition:   Diabetes Interventions:   Other: Follow-up questionnaires;   Other: Interviews Sponsor:   Direction Centrale du Service de Santé des Armées Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04739124?term=diabetes&sfpd_d=14 February 04, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: The Impact of Food Order on Glycemic Excursions in Type 2 Diabetes Assessed by Continuous Glucose Monitoring Published on: February 04, 2021 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Behavioral: Carbohydrate-Last Meal Sequence;   Behavioral: Carbohydrate-First Meal Sequence Sponsor:   Weill Medical College of Cornell University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04738799?term=diabetes&sfpd_d=14 February 04, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: mHealth Intervention to Support Diabetes Medication Adherence (Pilot Study) Published on: February 04, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Device: DIABE-TEXT Sponsor:   Fundació d'investigació Sanitària de les Illes Balears Recruiting https://clinicaltrials.gov/ct2/show/NCT04738591?term=diabetes&sfpd_d=14 February 04, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes Published on: February 04, 2021 at 07:00PM Condition:   Type 2 Diabetes Treated With Insulin Interventions:   Drug: premixed insulin therapy;   Drug: basal bolus insulin therapy Sponsor:   Consorci Sanitari Integral Completed https://clinicaltrials.gov/ct2/show/NCT04739241?term=diabetes&sfpd_d=14 February 04, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Culturally Appropriate Strategies for Chinese Americans With Diabetes (CASCADe) Published on: February 04, 2021 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Behavioral: CASCADe Sponsors:   Claremont Graduate University;   AHMC Health Foundation Completed https://clinicaltrials.gov/ct2/show/NCT04737499?term=diabetes&sfpd_d=14 February 04, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic Published on: February 04, 2021 at 07:00PM Condition:   Type2 Diabetes Intervention:   Other: Digital Storytelling Intervention Sponsors:   Mayo Clinic;   Hennepin Healthcare Research Institute;   Mountain Park Health Center Completed https://clinicaltrials.gov/ct2/show/NCT04738032?term=diabetes&sfpd_d=14 February 04, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Post-operative Complications and Graft Survival With Conventional Versus Continuous Glucose Monitoring in Patients With Diabetes Mellitus Undergoing Renal Transplantation Published on: February 05, 2021 at 07:00PM Condition:   Diabetes Mellitus Interventions:   Device: Continuous Glucose Monitor Application;   Diagnostic Test: Finger Stick Glucose Measurement;   Drug: Insulin;   Device: Continuous Glucose Monitor Placebo Applied Sponsor:   Northwell Health Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT04742023?term=diabetes&sfpd_d=14 February 05, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Parent Intervention to Prevent Disordered Eating in Children With Type 1 Diabetes Published on: February 05, 2021 at 07:00PM Conditions:   Diabetes Mellitus, Type 1;   Disordered Eating;   Children, Only;   Eating Disorders;   Parents Intervention:   Behavioral: Parental psychoeducational Intervention Sponsor:   University of Surrey Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04741568?term=diabetes&sfpd_d=14 February 05, 2021 at 02:24PM via ClinicalTrials.gov

Weekly Digest: New diabetes clinical trial (7 items)

New diabetes clinical trial: An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer Published on: February 08, 2021 at 07:00PM Conditions:   PreDiabetes;   Adult Children Interventions:   Drug: Metformin;   Behavioral: Digital Intervention Sponsors:   St. Jude Children's Research Hospital;   St. Baldrick's Foundation Recruiting https://clinicaltrials.gov/ct2/show/NCT04742751?term=diabetes&sfpd_d=14 February 08, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Online Diabetes Education Project (ODEP) Published on: February 08, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Behavioral: Virtual Diabetes Self-Management Education and Support;   Behavioral: Resources Sponsor:   University of Michigan Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04743778?term=diabetes&sfpd_d=14 February 08, 2021 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Gestational Weight Gain Criteria for Pregnant Women With Gestational Diabetes Mellitus in China Published on: February 09, 2021 at 07:00PM Condition:   Gestational Weight Gain Intervention:   Sponsor:   Women's Hospital School Of Medicine Zhejiang University Recruiting https://clinicaltrials.gov/ct2/show/NCT04744714?term=diabetes&sfpd_d=14 February 09, 2021 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus Published on: February 09, 2021 at 07:00PM Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Other Sponsors:   Institut de Recherches Internationales Servier;   ADIR, a Servier Group company Completed https://clinicaltrials.gov/ct2/show/NCT04744636?term=diabetes&sfpd_d=14 February 09, 2021 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Evaluation of Efficacy and Safety of a Combination Containing Myo-inositol, D-chiro-inositol, Alpha-lactalbumin, Zinc and Extract of Gymnema Sylvestre in Subjects Diabetic Patients. Published on: February 09, 2021 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Dietary Supplement: Myo-inositol, D-chiro-inositol, Gymnema sylvestre, Zinc and Alpha-lactalbumin;   Dietary Supplement: Placebo Sponsor:   Lo.Li.Pharma s.r.l Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04745780?term=diabetes&sfpd_d=14 February 09, 2021 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Faecal Microbiota Transplantation for Patients With Diabetes Mellitus Type 1 and Severe Gastrointestinal Neuropathy Published on: February 10, 2021 at 07:00PM Conditions:   Faecal Microbiota Transplantation (FMT);   Diabetes Mellitus, Type 1;   Gastrointestinal Neuropathy Interventions:   Other: Faecal microbiota transplantation (FMT) capsules;   Other: Placebo capsules Sponsor:   University of Aarhus Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04749030?term=diabetes&sfpd_d=14 February 10, 2021 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of 360 Video and MAPS on Enrollment in the DPP Published on: February 10, 2021 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   PreDiabetes Interventions:   Behavioral: Mobile 360° Video intervention;   Behavioral: Motivation and Problem Solving (MAPS);   Behavioral: Risk notification/education Sponsors:   University of Utah;   Centers for Disease Control and Prevention Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04746781?term=diabetes&sfpd_d=14 February 10, 2021 at 04:24PM via ClinicalTrials.gov